{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:11:59Z","timestamp":1778717519509,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00766-8","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:02:39Z","timestamp":1775210559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma metabolomic profiling identifies a metabolic signature for non\u2013muscle-invasive bladder cancer independent of hematuria"],"prefix":"10.1186","volume":"21","author":[{"given":"Roberto","family":"Speziale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Iacovelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Anzillotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Puca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Carugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Toniatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Bove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"766_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and Risk Factors of Urothelial Bladder Cancer. Eur Urol. 2013;63:234\u201341.","journal-title":"Eur Urol"},{"key":"766_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL, et al. European Association of Urology Guidelines on Non\u2013muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur Urol. 2022;81:75\u201394.","journal-title":"Eur Urol"},{"key":"766_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","volume":"56","author":"BWG van Rhijn","year":"2009","unstructured":"van Rhijn BWG, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, et al. Recurrence and Progression of Disease in Non\u2013Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy. Eur Urol. 2009;56:430\u201342.","journal-title":"Eur Urol"},{"key":"766_CR4","doi-asserted-by":"publisher","first-page":"115473","DOI":"10.1016\/j.jpba.2023.115473","volume":"233","author":"K Ossoli\u0144ski","year":"2023","unstructured":"Ossoli\u0144ski K, Ruman T, Copi\u00e9 V, Tripet BP, Ko\u0142odziej A, P\u0142aza-Altamer A, et al. Targeted and untargeted urinary metabolic profiling of bladder cancer. J Pharm Biomed Anal. 2023;233:115473.","journal-title":"J Pharm Biomed Anal"},{"key":"766_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman JS, Kumar S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9:97.","journal-title":"Signal Transduct Target Ther"},{"key":"766_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","volume":"79","author":"T Re\u017een","year":"2022","unstructured":"Re\u017een T, Rozman D, Kov\u00e1cs T, Kov\u00e1cs P, Sipos A, Bai P, et al. The role of bile acids in carcinogenesis. Cell Mol Life Sci. 2022;79:243.","journal-title":"Cell Mol Life Sci"},{"key":"766_CR7","doi-asserted-by":"publisher","first-page":"9802","DOI":"10.1038\/s41598-023-36874-y","volume":"13","author":"J Nizio\u0142","year":"2023","unstructured":"Nizio\u0142 J, Ossoli\u0144ski K, P\u0142aza-Altamer A, Ko\u0142odziej A, Ossoli\u0144ska A, Ossoli\u0144ski T, et al. Untargeted urinary metabolomics for bladder cancer biomarker screening with ultrahigh-resolution mass spectrometry. Sci Rep. 2023;13:9802.","journal-title":"Sci Rep"},{"key":"766_CR8","doi-asserted-by":"publisher","first-page":"15156","DOI":"10.1038\/s41598-022-19576-9","volume":"12","author":"J Nizio\u0142","year":"2022","unstructured":"Nizio\u0142 J, Ossoli\u0144ski K, P\u0142aza-Altamer A, Ko\u0142odziej A, Ossoli\u0144ska A, Ossoli\u0144ski T, et al. Untargeted ultra-high-resolution mass spectrometry metabolomic profiling of blood serum in bladder cancer. Sci Rep. 2022;12:15156.","journal-title":"Sci Rep"},{"key":"766_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12859-021-04235-z","volume":"22","author":"J-Y Lin","year":"2021","unstructured":"Lin J-Y, Juo B-R, Yeh Y-H, Fu S-H, Chen Y-T, Chen C-L, et al. Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics. BMC Bioinformatics. 2021;22:305.","journal-title":"BMC Bioinformatics"},{"key":"766_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1021\/pr800545q","volume":"8","author":"MK Tuck","year":"2009","unstructured":"Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, et al. Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group. J Proteome Res. 2009;8:113\u20137.","journal-title":"J Proteome Res"},{"key":"766_CR11","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1038\/s41467-024-48009-6","volume":"15","author":"Z Pang","year":"2024","unstructured":"Pang Z, Xu L, Viau C, Lu Y, Salavati R, Basu N, et al. MetaboAnalystR 4.0: a unified LC-MS workflow for global metabolomics. Nat Commun. 2024;15:3675.","journal-title":"Nat Commun"},{"key":"766_CR12","doi-asserted-by":"crossref","unstructured":"L\u00ea S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. 2008;25.","DOI":"10.18637\/jss.v025.i01"},{"key":"766_CR13","doi-asserted-by":"crossref","unstructured":"Josse J, Husson F. missMDA: a package for handling missing values in multivariate data analysis. J Stat Softw. 2016;70.","DOI":"10.18637\/jss.v070.i01"},{"key":"766_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"766_CR15","doi-asserted-by":"publisher","first-page":"8384","DOI":"10.18632\/aging.204975","volume":"15","author":"Z Tan","year":"2023","unstructured":"Tan Z, Fu S, Zuo J, Wang J, Wang H. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer. Aging. 2023;15:8384\u2013407.","journal-title":"Aging"},{"key":"766_CR16","doi-asserted-by":"publisher","first-page":"9172","DOI":"10.1038\/s41598-018-27538-3","volume":"8","author":"A Loras","year":"2018","unstructured":"Loras A, Trassierra M, Sanjuan-Herr\u00e1ez D, Mart\u00ednez-Bisbal MC, Castell JV, Quint\u00e1s G, et al. Bladder cancer recurrence surveillance by urine metabolomics analysis. Sci Rep. 2018;8:9172.","journal-title":"Sci Rep"},{"key":"766_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ajur.2022.11.005","volume":"11","author":"HA Garc\u00eda-Perdomo","year":"2024","unstructured":"Garc\u00eda-Perdomo HA, D\u00e1vila-Raigoza AM, Korkes F. Metabolomics for the diagnosis of bladder cancer: A systematic review. Asian J Urol. 2024;11:221\u201341.","journal-title":"Asian J Urol"},{"key":"766_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1039\/C4MB00414K","volume":"11","author":"MN Triba","year":"2015","unstructured":"Triba MN, Le Moyec L, Amathieu R, Goossens C, Bouchemal N, Nahon P, et al. PLS\/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters. Mol Biosyst. 2015;11:13\u20139.","journal-title":"Mol Biosyst"},{"key":"766_CR19","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3390\/ijms25063347","volume":"25","author":"F Pereira","year":"2024","unstructured":"Pereira F, Domingues MR, Vitorino R, Guerra IMS, Santos LL, Ferreira JA, et al. Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review. Int J Mol Sci. 2024;25:3347.","journal-title":"Int J Mol Sci"},{"key":"766_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23:27\u201347.","journal-title":"Cell Metab"},{"key":"766_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/metabo13080961","volume":"13","author":"R Speziale","year":"2023","unstructured":"Speziale R, Montesano C, Di Pietro G, Cicero DO, Summa V, Monteagudo E, et al. The Urine Metabolome of R6\/2 and zQ175DN Huntington\u2019s Disease Mouse Models. Metabolites. 2023;13:961.","journal-title":"Metabolites"},{"key":"766_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.emc.2019.07.011","volume":"37","author":"GC Willis","year":"2019","unstructured":"Willis GC, Tewelde SZ. The Approach to the Patient with Hematuria. Emerg Med Clin North Am. 2019;37:755\u201369.","journal-title":"Emerg Med Clin North Am"},{"key":"766_CR23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41420-024-01883-x","volume":"10","author":"M Scimeca","year":"2024","unstructured":"Scimeca M, Bischof J, Bonfiglio R, Nale E, Iacovelli V, Carilli M, et al. Molecular profiling of a bladder cancer with very high tumour mutational burden. Cell Death Discov. 2024;10:202.","journal-title":"Cell Death Discov"},{"key":"766_CR24","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1021\/acs.jcim.4c01799","volume":"65","author":"E Forsgren","year":"2025","unstructured":"Forsgren E, Bj\u00f6rkblom B, Trygg J, Jonsson P. OPLS-Based Multiclass Classification and Data-Driven Interclass Relationship Discovery. J Chem Inf Model. 2025;65:1762\u201370.","journal-title":"J Chem Inf Model"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 2020;318:G554\u201373.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"766_CR26","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.7150\/ijbs.44774","volume":"16","author":"A Kumari","year":"2020","unstructured":"Kumari A, Pal Pathak D, Asthana S. Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism. Int J Biol Sci. 2020;16:2308\u201322.","journal-title":"Int J Biol Sci"},{"key":"766_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tips.2024.04.007","volume":"45","author":"AR Terry","year":"2024","unstructured":"Terry AR, Hay N. Emerging targets in lipid metabolism for cancer therapy. Trends Pharmacol Sci. 2024;45:537\u201351.","journal-title":"Trends Pharmacol Sci"},{"key":"766_CR28","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1158\/2159-8290.CD-20-1437","volume":"11","author":"F Puca","year":"2021","unstructured":"Puca F, Yu F, Bartolacci C, Pettazzoni P, Carugo A, Huang-Hobbs E, et al. Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma. Cancer Discov. 2021;11:2904\u201323.","journal-title":"Cancer Discov"},{"key":"766_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.tem.2016.10.005","volume":"28","author":"CE Cho","year":"2017","unstructured":"Cho CE, Caudill MA. Trimethylamine- N -Oxide: Friend, Foe, or Simply Caught in the Cross-Fire? Trends Endocrinol Metabolism. 2017;28:121\u201330.","journal-title":"Trends Endocrinol Metabolism"},{"key":"766_CR30","first-page":"1","volume":"2022","author":"Y-Y Yang","year":"2022","unstructured":"Yang Y-Y, Hong S-Y, Xun Y, Liu C-Q, Sun J-X, Xu J-Z, et al. Characterization of the Lipid Metabolism in Bladder Cancer to Guide Clinical Therapy. J Oncol. 2022;2022:1\u201312.","journal-title":"J Oncol"},{"key":"766_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/bju.15205","volume":"127","author":"SH Lee","year":"2021","unstructured":"Lee SH, Mahendran R, Tham SM, Thamboo TP, Chionh BJ, Lim YX, et al. Tryptophan\u2013kynurenine ratio as a biomarker of bladder cancer. BJU Int. 2021;127:445\u201353.","journal-title":"BJU Int"},{"key":"766_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18:379\u2013401.","journal-title":"Nat Rev Drug Discov"},{"key":"766_CR33","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liu Y, Sun J, Zhang W, Guo Z, Ma Q. Arachidonic acid metabolism in health and disease. MedComm (Beijing). 2023;4.","DOI":"10.1002\/mco2.363"},{"key":"766_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141\u201362.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00766-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00766-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:38:59Z","timestamp":1778715539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00766-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00766-8","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional ethics committee of San Camillo Forlanini Hospital (Rome, Italy), in accordance with the Declaration of Helsinki and its later amendments (approval number: STS CE Lazio 1\/Oss-823). All participants provided written informed consent prior to sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain data from any individual person.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}